XML 155 R35.htm IDEA: XBRL DOCUMENT v3.25.4
Segment Information (Tables)
 9 Months Ended 12 Months Ended
Sep. 30, 2025
Dec. 31, 2024
Segment Information [Abstract]    
Schedule of Consolidated Statements of Operations

The following table includes revenue, significant veterinary clinic and hospital operating expenses, and Adjusted Clinic EBITDA for the Company’s clinics, reconciled to the consolidated amounts included in the Company’s consolidated statements of operations:

 

   For the three months ended
September 30,		   For the nine months ended
September 30,		 
   2025   2024   2025   2024 
Revenue                
Service revenue  $      3,138,670   $2,969,748   $9,074,965   $9,735,585 
Product revenue   1,177,462    1,079,277    3,163,910    3,535,388 
Total Clinics level revenue   4,316,132    4,049,025    12,238,875    13,270,973 
                     
Operating expenses                    
Cost of service revenue (exclusive of depreciation and amortization, shown separately below)   2,678,940    2,568,085    7,253,536    7,705,972 
Cost of product revenue (exclusive of depreciation and amortization, shown separately below)   850,153    854,921    2,507,227    2,807,025 
General and administrative expenses   610,629    65,093    2,015,056    2,034,074 
Total Clinics level expenses   4,139,722    3,488,099    11,775,819    12,547,071 
                     
Adjusted Clinics EBITDA  $176,410   $560,926   $463,056   $723,902 
                     
Reconciliation of Adjusted Clinics EBITDA to net income                    
Depreciation and amortization   330,498    340,167    864,293    1,048,290 
Interest income   (4)   (44)   (25)   (46)
Interest expense   559,111    1,254,149    1,385,891    2,801,491 
Debt extinguishment loss   
-
    
-
    689,411    1,587,862 
Other income (expenses)   
-
    
-
    
-
    4,768 
Gain on sale of business   
-
    (467,049)        (467,049)
Corporate general and administrative   1,813,078    2,923,029    5,499,364    6,046,125 
Net Income  $(2,526,273)  $(3,489,326)  $(7,975,878)  $(10,297,539)

The following table includes revenue, significant veterinary clinic and hospital operating expenses, and Adjusted Clinic EBITDA for the Company’s clinics, reconciled to the consolidated amounts included in the Company’s consolidated statements of operations:

 

   For the year ended
December 31,		 
   2024   2023 
Revenue        
Service revenue  $12,188,526   $11,879,934 
Product revenue   4,403,583    4,795,459 
Total Clinics level revenue   16,592,109    16,675,393 
           
Operating expenses          
Cost of service revenue (exclusive of depreciation and amortization, shown separately below)   9,736,282    9,700,963 
Cost of product revenue (exclusive of depreciation and amortization, shown separately below)   3,563,279    3,420,515 
General and administrative expenses   2,688,157    3,056,702 
Total Clinics level expenses   15,987,718    16,178,180 
Adjusted Clinics EBITDA  $604,391   $497,213 
           
Reconciliation of Adjusted Clinics EBITDA to net loss          
Depreciation and amortization   1,308,619    1,252,539 
Gain on sale of business   (467,049)   
-
 
Loss on debt extinguishment   
-
    16,105 
Interest expense   3,098,237    2,538,710 
Loss on debt modification   2,134,218    927,054 
Beneficial conversion feature   
-
    4,137,261 
Other income (expenses)   4,768    (1,134)
Corporate general and administrative   8,733,195    6,419,585 
Impairment expense   56,664    
-
 
Net Loss  $(14,264,261)  $(14,792,907)